It develops in response to tumor-derived factors and releases IL10, IL12, TNFα, TNFβ, VEGF, CCL20, CCL22, and MMP9, thereby supporting tumor growth and metastases and acting as an immunosuppressant. The gene discussed is VEGFA; the disease is neoplasm.